Roche has provided the first evidence that its oral anaplastic lymphoma kinase (ALK) inhibitor for non-small cell lung cancer (NSCLC) could be key in...
FDA Approves Veopoz (pozelimab-bbfg) as the First Treatment for Children and Adults with CHAPLE DiseaseTARRYTOWN, N.Y., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals,...
Pictured: Cancer cells growing on the liver/iStock, Rasi Bhadramani The FDA on Monday approved Delcath Systems’ Hepzato Kit for the liver-directed treatment of adult...
Cell linesHuman and murine bladder cancer cells SV-HUC-1, RT4, UM-UC-3, T24, 5637, MB49 were obtained and cultured as previously described . For inducing the...
FDA Approves Talvey (talquetamab-tgvs), a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple MyelomaHORSHAM, Pa., Aug. 10, 2023 – The...
Accelerated US approval of a first-in-class bispecific antibody (BsAb) therapy offers a new option for a difficult-to-treat blood cancer.
The US Food and Drug Administration...
Dear Editor,Sebaceous glands (SG) contribute to 90% of the skin surface lipid production and play critical roles in regulating proper skin functions including epidermal...
<!----> US-based Kashiv Biosciences has successfully completed a Phase I trial for its Xolair biosimilar ADL018, the company’s latest biosimilar in its pipeline, in...
